• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物油组成会影响共给予的亲脂性药物大麻二酚的肠道淋巴转运和全身生物利用度。

Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiol.

机构信息

School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.

School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK; School of Pharmacy, Universita di Roma Tor Vergata, Rome, Italy.

出版信息

Int J Pharm. 2022 Aug 25;624:121947. doi: 10.1016/j.ijpharm.2022.121947. Epub 2022 Jun 23.

DOI:10.1016/j.ijpharm.2022.121947
PMID:35753538
Abstract

Although natural sesame oil has been shown to facilitate the lymphatic delivery and oral bioavailability of the highly lipophilic drug cannabidiol (CBD), considerable variability remains an unresolved challenge. Vegetable oils differ substantially in composition, which could lead to differences in promotion of intestinal lymphatic transport of lipophilic drugs. Therefore, the differences in composition of sesame, sunflower, peanut, soybean, olive and coconut oils and their corresponding role as vehicles in promoting CBD lymphatic targeting and bioavailability were investigated in this study. The comparative analysis suggests that the fatty acids profile of vegetable oils is overall similar to the fatty acids profile in the corresponding chylomicrons in rat lymph. However, arachidonic acid (C20:4), was introduced to chylomicrons from endogenous nondietary sources. Overall, fatty acid composition of natural vegetable oils vehicles affected the intestinal lymphatic transport and bioavailability of CBD following oral administration in this work. Olive oil led to the highest concentration of CBD in the lymphatic system and in the systemic circulation in comparison to the other natural vegetable oils following oral administration in rats.

摘要

尽管已证实天然芝麻油可促进高度亲脂性药物大麻二酚(CBD)的淋巴传递和口服生物利用度,但仍存在相当大的变异性,这是一个尚未解决的挑战。植物油在组成上有很大的差异,这可能导致促进亲脂性药物肠内淋巴转运的差异。因此,本研究考察了芝麻油、葵花籽油、花生油、大豆油、橄榄油和椰子油在组成上的差异及其作为载体促进 CBD 淋巴靶向和生物利用度的相应作用。比较分析表明,植物油的脂肪酸谱与大鼠淋巴中的乳糜微粒中的脂肪酸谱总体相似。然而,花生四烯酸(C20:4)是从内源性非饮食来源引入乳糜微粒的。总的来说,天然植物油载体的脂肪酸组成影响了 CBD 经口服给药后的肠道淋巴转运和生物利用度。与其他天然植物油相比,橄榄油在口服给予大鼠后,可使 CBD 在淋巴系统和全身循环中的浓度最高。

相似文献

1
Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiol.植物油组成会影响共给予的亲脂性药物大麻二酚的肠道淋巴转运和全身生物利用度。
Int J Pharm. 2022 Aug 25;624:121947. doi: 10.1016/j.ijpharm.2022.121947. Epub 2022 Jun 23.
2
Natural sesame oil is superior to pre-digested lipid formulations and purified triglycerides in promoting the intestinal lymphatic transport and systemic bioavailability of cannabidiol.天然芝麻油优于预消化脂肪乳剂和纯化甘油三酯,可促进大麻二酚的肠淋巴转运和全身生物利用度。
Eur J Pharm Biopharm. 2021 May;162:43-49. doi: 10.1016/j.ejpb.2021.02.013. Epub 2021 Mar 5.
3
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.肝首过效应与大麻二酚的淋巴吸收之间的相互作用及其对大麻二酚口服制剂的影响。
Clin Pharmacokinet. 2020 Dec;59(12):1493-1500. doi: 10.1007/s40262-020-00931-w.
4
Oral bioavailability assessment and intestinal lymphatic transport of Org 45697 and Org 46035, two highly lipophilic novel immunomodulator analogues.两种高度亲脂性新型免疫调节剂类似物Org 45697和Org 46035的口服生物利用度评估及肠道淋巴转运
Curr Drug Deliv. 2009 Aug;6(4):359-66. doi: 10.2174/156720109789000500. Epub 2009 Aug 1.
5
Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220.肠道淋巴转运对结构相似的合成亲脂性大麻素:右大麻酚和PRS-211,220口服生物利用度的不同影响
Eur J Pharm Sci. 2007 Aug;31(5):298-305. doi: 10.1016/j.ejps.2007.04.006. Epub 2007 May 5.
6
Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol.一种用于口服递送大麻二酚的自微乳药物传递系统的开发和药代动力学评价。
Eur J Pharm Sci. 2022 Jan 1;168:106058. doi: 10.1016/j.ejps.2021.106058. Epub 2021 Nov 8.
7
Absorption in rats of rapeseed, soybean, and sunflower oils before and following moderate heating.大鼠对适度加热前后的菜籽油、大豆油和葵花籽油的吸收情况。
Lipids. 1999 Jul;34(7):727-32. doi: 10.1007/s11745-999-0419-z.
8
Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers.健康志愿者中合成大麻素口服制剂的药代动力学研究。
Eur J Pharm Biopharm. 2020 Sep;154:108-115. doi: 10.1016/j.ejpb.2020.06.021. Epub 2020 Jul 4.
9
Inclusion of Medium-Chain Triglyceride in Lipid-Based Formulation of Cannabidiol Facilitates Micellar Solubilization In Vitro, but In Vivo Performance Remains Superior with Pure Sesame Oil Vehicle.在大麻二酚的脂质制剂中加入中链甘油三酯有助于体外胶束增溶,但纯芝麻油载体的体内性能仍然更优。
Pharmaceutics. 2021 Aug 27;13(9):1349. doi: 10.3390/pharmaceutics13091349.
10
Using the Absorption Cocktail Approach to Assess Differential Absorption Kinetics of Cannabidiol Administered in Lipid-Based Vehicles in Rats.采用吸收鸡尾酒法评估大鼠中以脂质体为载体的大麻二酚的差异吸收动力学。
Mol Pharm. 2020 Jun 1;17(6):1979-1986. doi: 10.1021/acs.molpharmaceut.0c00141. Epub 2020 May 13.

引用本文的文献

1
Pharmacokinetics of Cannabidiol in Rat Brain Tissue After Single-Dose Administration of Different Formulations.不同制剂单剂量给药后大鼠脑组织中大麻二酚的药代动力学
Molecules. 2025 Jun 20;30(13):2676. doi: 10.3390/molecules30132676.
2
Orally consumed cannabinoids: the effect of carrier oil on acute tissue distribution in male C57BL/6 mice.口服大麻素:载体油对雄性C57BL/6小鼠急性组织分布的影响。
J Cannabis Res. 2025 Jul 1;7(1):38. doi: 10.1186/s42238-025-00298-4.
3
Pharmacokinetics of cannabidiol, (-)--Δ-tetrahydrocannabinol, and their oxidative metabolites after intravenous and oral administration of a cannabidiol-dominant full-spectrum hemp product to beagle dogs.
在向比格犬静脉注射和口服一种以大麻二酚为主的全谱大麻产品后,大麻二酚、(-)-Δ-四氢大麻酚及其氧化代谢物的药代动力学。
Front Vet Sci. 2025 Apr 8;12:1556975. doi: 10.3389/fvets.2025.1556975. eCollection 2025.
4
Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD).新型脂质制剂可提高口服大麻二酚(CBD)的吸收率。
Pharmaceutics. 2024 Dec 1;16(12):1537. doi: 10.3390/pharmaceutics16121537.
5
In Vitro Predictive Model for Intestinal Lymphatic Uptake: Exploration of Additional Enhancers and Inhibitors.肠道淋巴摄取的体外预测模型:其他增强剂和抑制剂的探索
Pharmaceutics. 2024 Jun 5;16(6):768. doi: 10.3390/pharmaceutics16060768.
6
Strategies to Improve Cannabidiol Bioavailability and Drug Delivery.提高大麻二酚生物利用度和药物递送的策略。
Pharmaceuticals (Basel). 2024 Feb 13;17(2):244. doi: 10.3390/ph17020244.
7
Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies.影响耐药性发育性和癫痫性脑病患儿大麻二酚暴露因素的真实世界证据
Pharmaceutics. 2023 Aug 10;15(8):2120. doi: 10.3390/pharmaceutics15082120.